 Exane Derivatives grew its position in IGM Biosciences NASDAQ:IGMS by 19.8 in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,952 shares of the companys stock after purchasing an additional 322 shares during the period. Exane Derivatives holdings in IGM Biosciences were ... 